Clinical trial technology isn’t the barrier to interoperability; the economics are. Two industry leaders explain why nothing forces systems to connect.
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Empowering Caregivers With ePRO Technology For Cancer Support
Explore the importance of involving caregivers in the care process and how electronic patient-reported outcomes technology can facilitate communication, tracking, and collaboration.
-
Agentic AI Is Transforming Life Sciences Discovery And Operations
73% of pharma companies are planning or deploying agentic AI. Discover who’s leading and how intelligent agents are transforming R&D.
-
Combining Patient-Centric Technology and RWD For Comprehensive Evidence
Explore how by combining digital technologies with secondary RWD, researchers can gather a more holistic understanding of the patient.
-
How Analytics Are Shaping The Future Of Clinical Trial Risk Management
Explore how analytics are revolutionizing clinical trial risk management and shaping the future of risk mitigation.
-
The Ultimate Clinical Trial Tracking Checklist
Ensure 360° clinical trial management support with a CTMS that aggregates and reports on these fields faster and more efficiently than spreadsheet trackers and legacy clinical trial data systems.
-
What Are Decentralized Clinical Trials (DCTs)?
Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
ICH E6(R3) Is Here: What Your Centralized Monitoring Strategy Needs
ICH E6(R3) turns best practices into regulatory mandates. Learn how to maintain sponsor accountability and implement proportionate centralized monitoring through a unified, auditable data layer.
-
Control And Transparency: Solving Sponsors' Key Challenges In Study Launch
Learn how SaaS technology can revolutionize clinical trial launches by improving transparency, increasing control, and streamlining efficiency.
-
Navigating The eCOA Vendor Landscape In 2025
This guide offers a clear-eyed perspective on the current eCOA landscape, providing sponsors with actionable guidance to make confident, informed vendor choices.
-
Creating Success With Digital Measures
Recent research from the Tufts Center for the Study of Drug Development (CSDD) illuminated the substantial ROI of digital endpoints in clinical trials. Discover how to transform your trials today.
RECENT NEWSLETTERS
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads